By exploiting the advantages of our boron chemistry platform, we have discovered and advanced into clinical development several novel and proprietary boron-based product candidates that address attractive market opportunities.

[ View pipeline ]

June 10, 2009 | Anacor Co-Founders Recognized For Scientific Achievements

June 2, 2009 | Anacor To Present At Needham Life Sciences Conference

May 27, 2009 | Anacor Announces Collaborations with TB Alliance and DNDi to Apply Boron Technology to Identify New Medicines for Neglected Diseases

[ View all news ]